Recipharm offers serialization for China regs; Dalton expands Toronto plant; U.S. and China fight over vitamin C

> Recipharm has launched a serialization project for a customer in China. Report

> CDMO Dalton Pharma, supported by a $2 million state grant, has expanded its sterile powder filling capabilities at its plant in Toronto, Canada. Release

> Moorfields Eye Hospital NHS Foundation Trust has decided to close its Moorfields Pharmaceuticals' central London compounding production facility, which suspended operations more than a year ago after an MHRA inspection raised some quality concerns. Release

> Dominance of Chinese makers on the vitamin C ingredient market is being challenged in U.S. court. Story

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.